Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Filgrastim (neupogen) (1 trial)
sargramostim (leukine) (2 trials)
autologous hematopoietic stem cells (2 trials)
bone autograft (1 trial)
cyclophosphamide (cytoxan) (8 trials)
docetaxel (taxotere) (1 trial)
doxorubicin (Doxil) (3 trials)
epirubicin (ellence) (1 trial)
fluorouracil (efudex) (7 trials)
goserelin (zoladex) (2 trials)
leuprolide (lupron) (2 trials)
naltrexone (revia) (7 trials)
tamoxifen (nolvadex) (7 trials)
temsirolimus (torisel) (5 trials)
thiotepa (2 trials)
vinorelbine (navelbine) (5 trials)
Breast Neoplasms (Phase 4)
Inflammatory Breast Neoplasms (Phase 3)
Neutropenia (Phase 4)
Trials (9 total)
Trial APIs (16 total)